Senior Director at J&J Innovation Center-Boston
Kuldeep Neote, Ph.D., is Senior Director at J&J Innovation Center-Boston,
and is responsible for New Venture and Scouting opportunities in the areas
of Oncology and Immunology in the East Coast.
Dr. Neote is trained as a Molecular Biologist with an extensive background
in drug discovery. He has focused in the area of Immunology, Inflammation
and Oncology and has a passion for implementing cutting edge scientific
discoveries into practical drug discovery programs. Throughout his career,
he has looked at creative scientific and business development collaborative
and partnering opportunities that have resulted in tangible clinical
translation of new scientific discoveries working in conjunction with
academic and biotech companies.
Formerly, Dr. Neote was Research Advisor/Director in Global External R&D
at Eli Lilly in Indianapolis, IN. Prior to Eli Lilly, he was a Discovery Scientist in
Pfizer Inc. in Groton, CT. Dr. Neote initiated the Chemokine Receptor Drug
Discovery platform that lead to several clinical candidates, and also
discovered novel chemokines. Earlier in his career, Dr. Neote cloned one of
the first chemokine receptors during his post-doctoral studies in
Dr. Neote earned his BSc. in Microbial and Cellular Biology at the University
of Calgary, Calgary, Canada, and a Ph.D. in Human and Molecule Genetics
at the University of Toronto, Toronto, Canada, where he was a major
contributor in the understanding of the molecular basis of lysosomal
storage diseases, in particular Tay Sachs and Sandhoff’s disease.